Vicente Quintanilla-Gonzalez

Santander, CB, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 65 publications

Impaired bone status in high frequency episodic or chronic migraine women: A case-control study with blood and densitometric parameters.

Impaired bone status in high frequency episodic or chronic migraine women: A case-control study with blood and densitometric parameters.

Journal: Cephalalgia : an international journal of headache

Published: June 24, 2026

Is achieving higher standards in real-world migraine care feasible with anti-CGRP monoclonal antibodies preventive therapies?: Insights from the EUREkA cohort.

Is achieving higher standards in real-world migraine care feasible with anti-CGRP monoclonal antibodies preventive therapies?: Insights from the EUREkA cohort.

Journal: Cephalalgia : an international journal of headache

Published: June 19, 2026

Long-Term Effectiveness and Persistence Factors of Anti-CGRP Monoclonal Antibodies in Migraine: 2-Year Results From the EUREkA Cohort.

Long-Term Effectiveness and Persistence Factors of Anti-CGRP Monoclonal Antibodies in Migraine: 2-Year Results From the EUREkA Cohort.

Journal: Neurology

Published: May 27, 2026

Correction: Switching strategies with CGRP monoclonal antibodies: an observational study in a headache clinic.

Correction: Switching strategies with CGRP monoclonal antibodies: an observational study in a headache clinic.

Journal: Frontiers in neurology

Published: April 01, 2026

Switching strategies with CGRP monoclonal antibodies: an observational study in a headache clinic.

Switching strategies with CGRP monoclonal antibodies: an observational study in a headache clinic.

Journal: Frontiers in neurology

Published: January 30, 2026

Long-Term Effectiveness and Persistence Factors of Anti-CGRP Monoclonal Antibodies in Migraine: 2-Year Results From the EUREkA Cohort.

Long-Term Effectiveness and Persistence Factors of Anti-CGRP Monoclonal Antibodies in Migraine: 2-Year Results From the EUREkA Cohort.

Journal: Neurology

Published: January 28, 2026

Real-world siponimod use in secondary progressive multiple sclerosis: the RESYZE study.

Real-world siponimod use in secondary progressive multiple sclerosis: the RESYZE study.

Journal: Therapeutic advances in neurological disorders

Published: January 14, 2026

SAFE-CGRP study: multicenter retrospective evaluation of the safety of CGRP pathway-targeting monoclonal antibodies in migraine with relevant comorbidities or conditions excluded from trials.

SAFE-CGRP study: multicenter retrospective evaluation of the safety of CGRP pathway-targeting monoclonal antibodies in migraine with relevant comorbidities or conditions excluded from trials.

Journal: Frontiers in neurology

Published: September 12, 2025

Evaluation of the effectiveness and safety of anti-CGRP monoclonal antibodies in patients with migraine and autoimmune diseases: IMMUNO-CGRP study.

Evaluation of the effectiveness and safety of anti-CGRP monoclonal antibodies in patients with migraine and autoimmune diseases: IMMUNO-CGRP study.

Journal: Headache

Published: September 06, 2025

Plasma with Added Protease Inhibitors Improves Alpha- and Beta-CGRP Measurement Compared to Serum: Towards a Reliable Biomarker for Chronic Migraine.

Plasma with Added Protease Inhibitors Improves Alpha- and Beta-CGRP Measurement Compared to Serum: Towards a Reliable Biomarker for Chronic Migraine.

Journal: International journal of molecular sciences

Published: September 05, 2025

From Molecules to Models: miRNAs and Advanced Human Platforms of Neurodegeneration and Repair in Multiple Sclerosis.

From Molecules to Models: miRNAs and Advanced Human Platforms of Neurodegeneration and Repair in Multiple Sclerosis.

Journal: International journal of molecular sciences

Published: July 18, 2025

Is headache training improving during neurology residency in Spain? A ten-year comparative study from the dual perspective of residents and tutors.

Is headache training improving during neurology residency in Spain? A ten-year comparative study from the dual perspective of residents and tutors.

Journal: Neurologia

Published: July 16, 2025

Showing 1-12 of 65

Last Updated: 09/26/2026